G 619, a dual thromboxane synthase inhibitor and thromboxane A 2 receptor antagonist, inhibits tumor necrosis factor- biosynthesis

By Altavilla D.   Squadrito F.   Canale P.   Ioculano M.   Squadrito G.   Campo G.M.   Serrano M.   Sardella A.   Urna G.   Spignoli G.   Caputi A.P.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite

Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery

By Kawano K.-i.   Ikeda Y.   Kondo K.   Umemura K.  

European Journal of Pharmacology, Vol. 374, Iss. 3, 1999-06 ,pp. : 377-385

Elsevier

Access to resources Recommend Favorite

Update on GPIIb/IIIa antagonists

By Hanson Julien   de Leval Xavier   Kolh Philippe   Supuran Claudiu   Pirotte Bernard   Dogné Jean-Michel  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 8, 2003-08 ,pp. : 1173-1188

Informa Healthcare

Access to resources Recommend Favorite

Antithrombotic activity of AT-1015, a potent 5-HT 2A receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time

By Kihara H.   Koganei H.   Hirose K.   Yamamoto H.   Yoshimoto R.  

European Journal of Pharmacology, Vol. 433, Iss. 2, 2001-12 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite

Choice of GPIIb/IIIa antagonist in percutaneous coronary intervention: how should economic criteria be factored in?

By Pen Claude   Lilliu Hervé  

Pharmacy World and Science, Vol. 27, Iss. 2, 2005-04 ,pp. : 83-91

Springer Publishing Company

Access to resources Recommend Favorite